Overview
Jonathan Serody is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Serody has been practicing medicine for over 37 years and is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Serody is currently accepting new patients.
His clinical research consists of co-authoring 117 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Triple-Negative Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Duke Cancer Center
My clinical practice if focused on the care of patients with breast cancer, particularly those diagnosed at a younger age and those with recurrence in the central nervous system. I am committed to the care of patients with breast cancer brain metastases, and I am honored to serve as the Medical Director of the Brain and Spine Metastases Program in the Duke Cancer Center. In this role, our multidisciplinary team provides well-coordinated care for patients with breast cancer and other solid tumor types that have metastasized to the central nervous system. In addition, I enjoy helping young women diagnosed with breast cancer navigate their treatment decisions to ensure both excellent medical care and attention to individual challenges, such as future fertility, sequelae of treatment on longer-term health, and impact on current and future relationships. When not working, I enjoy running, reading, and traveling with my family. Dr. Anders is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Brain Tumor, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer.
University Of North Carolina At Chapel Hill
Elizabeth Dees is an Oncologist and a Hematologist in Hillsborough, North Carolina. Dr. Dees is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Dees is currently accepting new patients.
University Of North Carolina At Chapel Hill
Mark Woodcock is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Woodcock is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Triple-Negative Breast Cancer, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Gastrointestinal Stromal Tumor. Dr. Woodcock is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Graft Versus Host Disease (GvHD)
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Serody isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Chronic Graft Versus Host Disease (cGvHD)Dr. Serody isDistinguished. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Triple-Negative Breast CancerDr. Serody isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Bone Marrow TransplantDr. Serody isAdvanced. Learn about Bone Marrow Transplant.
- Breast CancerDr. Serody isAdvanced. Learn about Breast Cancer.
- Hodgkin LymphomaDr. Serody isAdvanced. Learn about Hodgkin Lymphoma.
- Multiple MyelomaDr. Serody isAdvanced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Serody isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Serody isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- AgranulocytosisDr. Serody isExperienced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Serody isExperienced. Learn about Aplastic Anemia.
- Bladder CancerDr. Serody isExperienced. Learn about Bladder Cancer.
- Bone Marrow AspirationDr. Serody isExperienced. Learn about Bone Marrow Aspiration.
